Acadia Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Acadia Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Acadia Pharmaceuticals Inc Strategy Report
- Understand Acadia Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Acadia Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Acadia Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Stephen R. Biggar, M.D., Ph.D.
Chairman Executive BoardDr. Stephen R. Biggar has been the Chairman of the company since 2016. Prior to this, he served as the Director of the company since 2013. Dr. Biggar is a partner at Baker Brothers Investments, a fund management company. From 2002 to 2006, he served as a Principal with Baker Brothers Investments. He also served as a Director for Synageva BioPharma Corp.
Stephen R. Davis
President; Director; Chief Executive Officer Executive BoardMr. Stephen R. Davis has been the Chief Executive Officer and President of the company since September 2015. Prior to this, he was the Chief Financial Officer, the Chief Business Officer and the Executive Vice President of the company. Mr. Davis also served as the Executive Vice President and the Chief Operating Officer at Heron Therapeutics, Inc. since 2013; Executive Vice President and Chief Operating Officer at Ardea Biosciences, Inc. He served as board of directors of Synageva BioPharma Corp., Heron Therapeutics and Furiex Pharmaceuticals, Inc.
Mark C. Schneyer
Chief Financial Officer; Executive Vice President Senior ManagementMr. Mark Schneyer has been the Executive Vice President and Chief Financial Officer of the company since 2021. Prior to this he served as the Interim Chief Financial Officer of the company. He also serves as Senior Vice President, Business Development and Chief Business Officer of the company since 2020. Prior to this role, he served as Vice President, Business Development, for the Upjohn division at Pfizer Inc. Previously, he served as investment banker at Lazard.
Brendan P. Teehan
Executive Vice President; Head - Commercial; Chief Operating Officer Senior ManagementMr. Brendan Teehan has been the Executive Vice President, Chief Operating Officer, and Head of Commercial division of the company since 2021. Previously, he served as Senior Vice President and the Chief Insights & Analytics Officer of the company since July 2018. Previously, he served at Tesaro Inc as the Vice President, building and leading the Provider Solutions Department.
Jennifer J. Rhodes
Secretary; Executive Vice President; Chief Legal Officer Senior ManagementMs. Jennifer J. Rhodes has been the Executive Vice President, Chief Legal Officer, and Secretary of the company since January 2024. Previously, she served as Executive Vice President, General Counsel, and Chief Business Officer at Angion Biomedica. Prior to this, Ms. Rhodes served as General Counsel, Chief Business Officer, and Corporate Secretary at Adamas Pharmaceuticals. Earlier, She served in executive legal and compliance roles at Medivation and senior legal roles at Pfizer.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer